EpiPen maker settles federal claims for $465M a year after Sanofi filed suit
August 17, 2017 at 12:48 PM EDT
As a result of today’s settlement, Sanofi will get $38.7 million as its share of the federal recovery, plus a share of the states’ recovery.
